Lv61
1950 积分 2022-05-24 加入
Glecirasib in KRASG12C-mutated nonsmall-cell lung cancer: a phase 2b trial
20天前
已完结
Garsorasib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 2 trial
2个月前
已完结
Efficacy and Safety of Hedgehog Inhibitors for Advanced Basal Cell Carcinoma: An Expert Consensus Panel
3个月前
已完结
Efficacy and Safety of Hedgehog Inhibitors for Advanced Basal Cell Carcinoma: An Expert Consensus Panel
4个月前
已关闭
Current treatment options for locally advanced and metastatic basal cell carcinoma. A narrative review
4个月前
已完结
Efficacy and Safety of Hedgehog Inhibitors for Advanced Basal Cell Carcinoma: An Expert Consensus Panel
4个月前
已关闭
Hedgehog signaling pathway inhibitors in the treatment of basal cell carcinoma: An Updated Review
4个月前
已完结
Real‐world data on the efficacy and safety of hedgehog pathway inhibitors in patients with basal cell carcinoma: Experience of a tertiary Australian centre
7个月前
已完结
Efficacité du sonidégib dans un cas de carcinome basosquameux avec métastase ganglionnaire
7个月前
已关闭
An updated overview of K-RAS G12C inhibitors in advanced stage non-small cell lung cancer
10个月前
已完结
皖公网安备34019202002308
